These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 19365279

  • 21. The medical management of acute coronary syndromes and potential roles for new antithrombotic agents.
    Pollack CV, Goldberg AD.
    J Emerg Med; 2008 May; 34(4):417-28. PubMed ID: 18226874
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Low-molecular-weight heparins in acute coronary syndrome: acquired results and new perspectives].
    Ugo F, Ardissino D.
    G Ital Cardiol (Rome); 2006 Dec; 7(12):771-9. PubMed ID: 17294602
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Anticoagulants in coronary artery disease.
    Lee LV.
    Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antithrombotics and anticoagulants in coronary syndromes and stroke.
    Turpie AG.
    Semin Thromb Hemost; 2000 Nov; 26 Suppl 1():79-83. PubMed ID: 11011811
    [Abstract] [Full Text] [Related]

  • 33. Economic evaluation of the use of enoxaparin in non-ST-elevation acute coronary syndrome.
    Nutescu EA, Steinmetz Pater K.
    Expert Opin Pharmacother; 2008 Jan; 9(1):95-105. PubMed ID: 18076341
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention.
    Wong GC, Giugliano RP, Antman EM.
    JAMA; 2003 Jan 15; 289(3):331-42. PubMed ID: 12525234
    [Abstract] [Full Text] [Related]

  • 36. M118--a rationally engineered low-molecular-weight heparin designed specifically for the treatment of acute coronary syndromes.
    Kishimoto TK, Qi YW, Long A, Capila I, Sasisekharan R, Guerrero L, Fier I, Roach J, Venkataraman G.
    Thromb Haemost; 2009 Nov 15; 102(5):900-6. PubMed ID: 19888526
    [Abstract] [Full Text] [Related]

  • 37. [Anticoagulant and thrombolytic agents in acute coronary syndromes].
    Schwarz M, Saurbier B, Bode C.
    Hamostaseologie; 2008 Dec 15; 28(5):438-47. PubMed ID: 19132173
    [Abstract] [Full Text] [Related]

  • 38. Prevention of cardiovascular events after acute coronary syndrome.
    Wallentin L.
    Semin Vasc Med; 2005 Aug 15; 5(3):293-300. PubMed ID: 16123917
    [Abstract] [Full Text] [Related]

  • 39. Successors to heparin: new antithrombotic agents.
    Turpie AG.
    Am Heart J; 1997 Nov 15; 134(5 Pt 2):S71-7. PubMed ID: 9396637
    [Abstract] [Full Text] [Related]

  • 40. Low-molecular-weight heparin: an antithrombotic agent whose time has come.
    Futterman LG, Lemberg L.
    Am J Crit Care; 1999 Jan 15; 8(1):520-3. PubMed ID: 9987551
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.